High frequency of Plasmodium falciparum CICNI/SGEAA and CVIET haplotypes without association with resistance to sulfadoxine/pyrimethamine and chloroquine combination in the Daraweesh area, in Sudan

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 8, 2008, Pages 725-732

  A Elbasit, I E ^a   Khalil, I F ^b   Elbashir, M I ^a   Masuadi, E M ^c   Bygbjerg, I C ^b   Alifrangis, M ^b   Giha, H A ^a,c  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DHFR GENE; DHPS GENE; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MONOTHERAPY; NONHUMAN; PFCRT GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUDAN; TREATMENT FAILURE;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; HUMANS; MUTATION; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SUDAN; SULFADOXINE;

EID: 48449094768     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0499-1     Document Type: Article

References (32)

1. B Greenwood T Mutabingwa 2002 Malaria in 2002 Nature 415 670 672
2. JF Trape G Pison MP Preziosi C Enel A Desgrées du Loû V Delaunay B Samb E Lagarde JF Molez F Simondon 1998 Impact of chloroquine resistance on malaria mortality C R Acad Sci III 321 689 697
3. NJ White 1998 Preventing antimalarial drug resistance through combinations Drug Resist Updat 1 3 9
4. E Ayala AG Lescano RH Gilman M Calderón VV Pinedo H Terry L Cabrera JM Vinetz 2006 Polymerase chain reaction and molecular genotyping to monitor parasitological response to anti-malarial chemotherapy in the Peruvian Amazon Am J Trop Med Hyg 74 546 553
5. C Wongsrichanalai AL Pickard WH Wernsdorfer SR Meshnick 2002 Epidemiology of drug-resistant malaria Lancet Infect Dis 2 209 218
6. IE A-Elbasit MI Elbashir IF Khalil M Alifrangis HA Giha 2006 The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis Trop Med Int Health 11 604 612
7. NJ White 2004 Antimalarial drug resistance J Clin Invest 113 1084 1092
8. DS Peterson D Walliker TE Wellems 1988 Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria Proc Natl Acad Sci USA 85 9114 9118
9. T Triglia JG Menting C Wilson AF Cowman 1997 Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum Proc Natl Acad Sci USA 94 13944 13949
10. DR Brooks P Wang M Read WM Watkins PF Sims JE Hyde 1994 Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine Eur J Biochem 224 397 405
11. AF Cowman MJ Morry BA Biggs GA Cross SJ Foote 1988 Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum Proc Natl Acad Sci USA 85 9109 9113
12. JG Kublin FK Dzinjalamala DD Kamwendo EM Malkin JF Cortese LM Martino RA Mukadam SJ Rogerson AG Lescano ME Molyneux PA Winstanley P Chimpeni TE Taylor CV Plowe 2002 Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria J Infect Dis 185 380 388
13. AM Nzila EK Mberu J Sulo H Dayo PA Winstanley CH Sibley WM Watkins 2000 Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites Antimicrob Agents Chemother 44 991 996
14. HA Babiker SJ Pringle A Abdel-Muhsin M Mackinnon P Hunt D Walliker 2001 High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1 J Infect Dis 15 1535 1538
15. G Dorsey MR Kamya A Singh PJ Rosenthal 2001 Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda J Infect Dis 183 1417 1420
16. JC Wootton X Feng MT Ferdig RA Cooper J Mu DI Baruch AJ Magill XZ Su 2002 Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum Nature 418 320 323
17. World Health Organization (WHO) (1996) Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated malaria in areas with intense transmission. WHO, Geneva, WHO/MAL/96.1077
18. M Alifrangis S Enosse R Pearce C Drakeley C Roper IF Khalil WM Nkya AM Rønn TG Theander IC Bygbjerg 2005 A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction and enzyme-linked immunosorbent assay-based technology Am J Trop Med Hyg 72 155 162
19. CV Plowe 2003 Monitoring antimalarial drug resistance: making the most of the tools at hand J Exp Biol 206 3745 3752
20. I Khalil M Alifrangis AM Rønn HA Gabar T Jelinek GM Satti IC Bygbjerg 2002 Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome Am J Trop Med Hyg 67 225 229
21. AM Abdel-Muhsin MJ Mackinnon E Ali el-KA Nassir S Suleiman S Ahmed D Walliker HA Babiker 2004 Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan J Infect Dis 189 1239 1244
22. ME Osman FP Mockenhaupt U Bienzle MI Elbashir HA Giha 2007 Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum Infect Genet Evol 7 52 59
23. TJ Anderson S Nair C Jacobzone A Zavai S Balkan 2003 Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan Trop Med Int Health 8 1068 1073
24. S Hamour Y Melaku K Keus J Wambugu S Atkin J Montgomery N Ford C Hook F Checchi 2005 Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations Trans R Soc Trop Med Hyg 99 548 554
25. T Jelinek AH Kilian G Kabagambe F von Sonnenburg 1999 Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes Am J Trop Med Hyg 61 463 466
26. D Ndiaye JP Daily O Sarr O Ndir O Gaye S Mboup DF Wirth 2005 Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal Trop Med Int Health 10 1176 1179
27. AM McCollum AC Poe M Hamel C Huber Z Zhou YP Shi P Ouma J Vulule P Bloland L Slutsker JW Barnwell V Udhayakumar AA Escalante 2006 Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles J Infect Dis 194 189 197
28. RJ Pearce C Drakeley D Chandramohan F Mosha C Roper 2003 Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania Antimicrob Agents Chemother 47 1347 1354
29. SA Omar IS Adagu DC Warhurst 2001 Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Trans R Soc Trop Med Hyg 95 315 319
30. IE A-Elbasit M Alifrangis IF Khalil IC Bygbjerg EM Masuadi MI Elbashir HA Giha 2007 The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics Malar J 6 108
31. RK Mehlotra H Fujioka PD Roepe O Janneh LM Ursos V Jacobs-Lorena DT McNamara MJ Bockarie JW Kazura DE Kyle DA Fidock PA Zimmerman 2001 Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America Proc Natl Acad Sci USA 23 12689 12694
32. M Alifrangis MB Dalgaard JP Lusingu LS Vestergaard T Staalsoe AT Jensen A Enevold AM Rønn IF Khalil DC Warhurst MM Lemnge TG Theander IC Bygbjerg 2006 Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania J Infect Dis 15 1738 1741